CRMD vs NDAQ · P/E 3.9, rev $43.5M vs P/E 41, rev $2.53B
CorMedix Inc (CRMD) versus Nasdaq Inc (NDAQ) — a side-by-side from cached financials, not a winner call.
CorMedix Inc (CRMD) is a biotechnology company listed on US.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Latest reported CRMD revenue for 2024-12-31 was $43.5M. Net income was -$17.9M. Revenue was up 66363.1% from 2022-12-31 to 2024-12-31. CRMD currently screens at market cap $655.9M and trailing P/E 3.9.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
CRMD currently screens at market cap $655.9M and trailing P/E 3.9. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Not investment advice. Open the CRMD and NDAQ stock pages for the full models.
Not investment advice.